Posted in Clinical Data Maze tumbles despite positive data for kidney disease drug March 25, 2026 BioPharma Dive Investors had reservations about data for a drug that could compete with a candidate from Vertex in APOL1-mediated kidney disease. Clinical DataRare DiseaseRead full story